BR vs. R‑miniCHOP in unfit patients with B‑cell non‑Hodgkin lymphoma: A randomized, two‑center, cohort study

The aim of the present study was to compare the efficacy and safety between the bendamustine plus rituximab (BR) regimen and rituximab combined with low-dose doxorubicin, cyclophosphamide, vincristine and prednisone (R-miniCHOP) in the treatment of ‘unfit’ patients with diffuse large B-cell lymphoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongdong, Lin, Yong, Dong, Youhong, Zhang, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472019/
https://www.ncbi.nlm.nih.gov/pubmed/37664664
http://dx.doi.org/10.3892/ol.2023.14027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472019/
https://www.ncbi.nlm.nih.gov/pubmed/37664664
http://dx.doi.org/10.3892/ol.2023.14027

Ejemplares similares